Literature DB >> 26841250

Contemporary retinal imaging techniques in diabetic retinopathy: a review.

Emily Dawn Cole1,2, Eduardo Amorim Novais1,3, Ricardo Noguera Louzada1,4, Nadia K Waheed1.   

Abstract

Over the last decade, there has been an expansion of imaging modalities available to clinicians to diagnose and monitor the treatment and progression of diabetic retinopathy. Recently, advances in image technologies related to OCT and OCT angiography have enabled improved visualization and understanding of this disease. In this review, we will describe the use of imaging techniques such as colour fundus photography, fundus autofluorescence, fluorescein angiography, infrared reflectance imaging, OCT, OCT-Angiography and techniques in adaptive optics and hyperspectral imaging in the diagnosis and management of diabetic retinopathy.
© 2016 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  OCT; OCT angiography; diabetic macular oedema; diabetic retinopathy; fluorescein angiography

Mesh:

Year:  2016        PMID: 26841250     DOI: 10.1111/ceo.12711

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  21 in total

Review 1.  Cellular-Scale Imaging of Transparent Retinal Structures and Processes Using Adaptive Optics Optical Coherence Tomography.

Authors:  Donald T Miller; Kazuhiro Kurokawa
Journal:  Annu Rev Vis Sci       Date:  2020-07-01       Impact factor: 6.422

Review 2.  Imaging and Biomarkers in Diabetic Macular Edema and Diabetic Retinopathy.

Authors:  Changyow C Kwan; Amani A Fawzi
Journal:  Curr Diab Rep       Date:  2019-08-31       Impact factor: 4.810

Review 3.  Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy.

Authors:  Irini Chatziralli; Sara Touhami; Maria Vittoria Cicinelli; Chrysa Agapitou; Eleni Dimitriou; George Theodossiadis; Panagiotis Theodossiadis
Journal:  Eye (Lond)       Date:  2021-08-18       Impact factor: 3.775

Review 4.  A Detailed Systematic Review on Retinal Image Segmentation Methods.

Authors:  Nihar Ranjan Panda; Ajit Kumar Sahoo
Journal:  J Digit Imaging       Date:  2022-05-04       Impact factor: 4.903

Review 5.  Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.

Authors:  Elia J Duh; Jennifer K Sun; Alan W Stitt
Journal:  JCI Insight       Date:  2017-07-20

6.  Visualization of 3 Distinct Retinal Plexuses by Projection-Resolved Optical Coherence Tomography Angiography in Diabetic Retinopathy.

Authors:  Thomas S Hwang; Miao Zhang; Kavita Bhavsar; Xinbo Zhang; J Peter Campbell; Phoebe Lin; Steven T Bailey; Christina J Flaxel; Andreas K Lauer; David J Wilson; David Huang; Yali Jia
Journal:  JAMA Ophthalmol       Date:  2016-12-01       Impact factor: 7.389

Review 7.  Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory.

Authors:  Pedro Romero-Aroca; Marc Baget-Bernaldiz; Alicia Pareja-Rios; Maribel Lopez-Galvez; Raul Navarro-Gil; Raquel Verges
Journal:  J Diabetes Res       Date:  2016-09-28       Impact factor: 4.011

8.  Diabetic Macular Ischemia Diagnosis: Comparison between Optical Coherence Tomography Angiography and Fluorescein Angiography.

Authors:  Jose Mauricio Botto de Barros Garcia; Talita Toledo Lima; Ricardo Noguera Louzada; Alessandra Thome Rassi; David Leonardo Cruvinel Isaac; Marcos Avila
Journal:  J Ophthalmol       Date:  2016-11-07       Impact factor: 1.909

9.  Detecting Visual Function Abnormality with a Contrast-Dependent Visual Test in Patients with Type 2 Diabetes.

Authors:  Li-Ting Tsai; Kuo-Meng Liao; Yuh Jang; Fu-Chang Hu; Wei-Chi Wu
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

10.  Parafoveal OCT Angiography Features in Diabetic Patients without Clinical Diabetic Retinopathy: A Qualitative and Quantitative Analysis.

Authors:  Mathilde M Goudot; Anne Sikorav; Oudy Semoun; Alexandra Miere; Camille Jung; Blandine Courbebaisse; Mayer Srour; Joseph G Freiha; Eric H Souied
Journal:  J Ophthalmol       Date:  2017-06-29       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.